Muhammad Sohail, MD
Infectious Disease · Houston, TXNPI 1265690911
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $37,292 of the $48,915 with a category attached, or 76.2%. Philips North America LLC accounts for 86.7% of it on its own, with 6 other manufacturers making up the rest. Reporting peaked in 2023 at $21,677 and has fallen 99.4% since, to $130 in 2025. Among infectious disease clinicians in TX with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 76 payments — averaging $643.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$42K
- Medtronic$3K
- Angiodynamics, Inc.$3K
- Elutia, Inc.$600
- Shionogi Inc$60
- Melinta Therapeutics, LLC$47
- plus $16 from 1 others
Across 6 payments — averaging $41,496 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Sanofi Pasteur Inc.$249K
What the payments were for
- Consulting fees$37,29276%
- Speaking & faculty fees$6001%
- Travel & lodging$9,97420%
- Food & beverage$9732%
- Education$760%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 64 | $42,429 |
| Medtronic | 1 | $3,150 |
| Angiodynamics, Inc. | 7 | $2,613 |
| Elutia, Inc. | 1 | $600 |
| Shionogi Inc | 1 | $60 |
| Melinta Therapeutics, LLC | 1 | $47 |
| Insmed, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- (9520) IGT Devices Undivided$37,604
- (9124) LM Undivided$4,093
- TYRX$3,150
- AngioVac$2,571
- ECM Patch,Pouch$600
- IGT Devices Und$206
How this compares
$48,915 in reported general payments places this provider in the 90th percentile of 576 infectious disease providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BiktarvyBictegrav/Emtricit/Tenofov Ala | 21 | $79,677 |
| Chlorhexidine Gluconate | 24 | $120 |
| Amoxicillin | 16 | $46 |
| Ibuprofen | 17 | $38 |
Paid to pharmacies, not to this prescriber.
Other infectious disease in Houston
- Joseph GatheHouston$695K
- Roy ChemalyHouston$686K
- Ben BarnettHouston$424K
- Amar SafdarHouston$284K
- Luis OstroskyHouston$173K
- Richard HamillHouston$137K
- Karen VigilHouston$91K
- John RexHouston$63K
- Pablo OkhuysenHouston$57K
- Rodrigo HasbunHouston$51K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.